Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Breast Neoplasms|Kidney Neoplasms|Pancreatic Neuroendocine Neoplasms (pNETs)
Interventions: DRUG: alpelisib|DRUG: everolimus|DRUG: exemestane
Sponsor: Novartis Pharmaceuticals